Cited by 312Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic DiseasesDiet, Metabolism, and Disease

The Role of Free Fatty Acid Metabolism in the Pathogenesis of Insulin Resistance in Obesity and Noninsulin-Dependent Diabetes Mellitus*

GROOP, LEIF C., SALORANTA, CAROLA, SHANK, MYRON, BONADONNA, RICCARDO C., FERRANNINI, ELEUTERIO, DEFRONZO, RALPH A.·1991·The Journal of Clinical Endocrinology & Metabolism

Abstract

To investigate the mechanisms of insulin resistance in obesity and noninsulin-dependent diabetes mellitus (NIDDM), we examined oxidative and nonoxidative pathways of free fatty acid (FFA) and glucose metabolism in 14 lean and 17 obese (with normal oral glucose tolerance) nondiabetic subjects and in 8 lean and 8 obese subjects with NIDDM. FFA and glucose metabolism were measured using the sequential insulin clamp technique in combination with indirect calorimetry and infusion of [3-3H]glucose and [1-14C]palmitate. Obesity was characterized by enlarged fat mass, which correlated positively with the plasma FFA concentration (r = 0.62; P less than 0.01). FFA metabolism was less sensitive to insulin in obese than in lean nondiabetic subjects, but this defect could be overcome by increasing the plasma insulin concentration. NIDDM patients showed normal sensitivity to the inhibitory action of insulin on FFA metabolism; however, maximal suppression by insulin was impaired. The combination of obesity and NIDDM was associated with a further enhancement of reesterification of FFA than observed in either condition alone. In both obesity and NIDDM, the dose-response curve for suppression of hepatic glucose production by insulin was impaired. While obesity was primarily characterized by reduced sensitivity to the stimulatory action of insulin on oxidative and nonoxidative pathways of glucose metabolism, resistance to the effect of insulin on glucose metabolism in NIDDM was characterized by a reduced maximal response. The combination of obesity and NIDDM further impaired the sensitivity of liver glucose output and glucose oxidation to insulin. The hypothesis is advanced that in uncomplicated obesity, increased availability and oxidation of FFA leads, by the FFA/glucose cycle, to the impairment in glucose utilization. In NIDDM, on the other hand, the defect in glucose utilization is primary, and the enhanced rate of FFA oxidation may represent a compensatory phenomenon.

Integrity signals

Registry

Crossref · 10.1210/jcem-72-1-96

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In insulin-resistant individuals, the ability of insulin to inhibit lipolysis and lower plasma free fatty acid concentration is markedly impaired, leading to increased lipolysis and chronic elevation of plasma free fatty acids.

    “In insulin resistant individuals, for example, nondiabetic obese and lean type 2 diabetic subjects, the ability of insulin to inhibit lipolysis and reduce plasma FFA concentration is markedly impaired [21, 59], leading to an increased rate of lipolysis and chronic elevation in the plasma FFA concentration.”

    From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [59]

  • Hepatic insulin sensitivity is decreased in obese type 2 diabetic patients as compared with nonobese nondiabetic subjects.

    “Hepatic insulin sensitivity has been shown to be decreased in obese type 2 diabetic patients as compared with nonobese nondiabetic subjects, [25][26][27]”
  • When age-, gender-, and weight-matched groups have been compared, hepatic insulin resistance has frequently been reported to be comparable.

    “but when age-, gender-, and weight-matched groups have been compared, hepatic insulin resistance has frequently been reported to be comparable.[27][28][29][30][31][32]”
  • S-free insulin concentrations during exogenously induced hyperinsulinemia have been found to be significantly higher in type 2 diabetic patients than in normal subjects in some studies.

    “S-free insulin concentrations during exogenously induced hyperinsulinemia have been found to be significantly higher in type 2 diabetic patients than in normal subjects in some of these studies.27,29”

The citation lists haven’t been fetched yet

References 39 · Cited by 312

Authors
GROOP, L. C., SALORANTA, C., SHANK, M., BONADONNA, R. C., FERRANNINI, E., & DEFRONZO, R. A.
Affiliations
University of Pisa (IT)
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
1991-01
Volume
72
Issue
1
Pages
96-107
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2002888717
Cited by
312
References
39
Citations by year
2025: 4 · 2024: 5 · 2023: 2 · 2022: 4 · 2021: 2 · 2020: 5 · 2019: 4 · 2018: 12 · 2017: 11 · 2016: 9 · 2015: 7 · 2014: 5 · 2013: 10 · 2012: 10
FWCI
7.55
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (AM 24 092, 5r01am024092-06)
  • Fogarty International Center (F05-TWO-3451)
  • National Center for Research Resources (RR 125)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
insulin resistance, free fatty acid metabolism, obesity, type 2 diabetes, hepatic glucose production, glucose oxidation, fatty acid re-esterification, insulin sensitivity, fatty acid oxidation, glucose utilization
MeSH terms
Adult, Blood Glucose, Diabetes Mellitus, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Male, Middle Aged, Obesity, Glucose Clamp Technique

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review